Repare Therapeutics (RPTX) Competitor Comparison
We are evaluating the key criteria listed to compare Repare Therapeutics (RPTX) against its competitors in the Biotechnology industry.
Market Capitalization
207 / 368Gross Profits
92 / 278Total Revenue
115 / 300EBITDA
204 / 337Free Cashflow
233 / 352Quick Ratio
173 / 357Earnings per Share
184 / 359Dividend yield
0 / 6Total Cash
132 / 358Performance 3 years
276 / 368Performance 5 years
275 / 368Performance 10 years
242 / 368Linearity 3 years
229 / 368Linearity 5 years
204 / 368Linearity 10 years
167 / 368Total Rank
31 / 368Dividend Rank
260 / 368Valuation Rank
26 / 368Piotroski Rank
29 / 368Muliplier Rank
37 / 368Dividend yield - RPTX ranking 0 / 6
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.